Protein detail

ADH1B

All-trans-retinol dehydrogenase [NAD(+)] ADH1B (EC 1.1.1.105) (Alcohol dehydrogenase 1B) (Alcohol dehydrogenase subunit beta)

Entry name
ADH1B
UniProt ID
EVMP confidence score
0.60
Supporting publications (n)
13
Transmembrane count
Protein classification
EnzymesFDA approved drug targetsHuman disease related genesMetabolic proteinsPlasma proteinsPredicted intracellular proteins
EVMP confidence score

Annotation confidence score; open for threshold definitions.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information11
Protein Names
All-trans-retinol dehydrogenase [NAD(+)] ADH1B (EC 1.1.1.105) (Alcohol dehydrogenase 1B) (Alcohol dehydrogenase subunit beta)
Protein Class (6)
EnzymesFDA approved drug targetsHuman disease related genesMetabolic proteinsPlasma proteinsPredicted intracellular proteins
Protein Function (5)
  • Human disease related genes:Other diseases:Mental and behavioural disorders
  • ENZYME proteins:Oxidoreductases
  • Predicted intracellular proteins
  • Enzymes
  • FDA approved drug targets:Small molecule drugs
Entrez Gene Symbol
Gene Synonym
ADH2
Gene Description
Alcohol dehydrogenase 1B (class I), beta polypeptide
Chromosome
4
Position
99304971-99352760
Supporting publications (n)
13
EVMP confidence score
0.60
Fluorescence & Localization2
Cell SpecificNeutrophilsBlood Cell Specificclassical monocyte
Function & Pathway7
Relations & Evidence7

Ligand-Receptor Signaling (5)

5 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
intracellularintracellularLOCATENoNoNoNoNo
intracellularintracellularComPPINoNoNoNoNo
intracellularintracellularGO_IntercellNoNoNoNoNo
intracellularintracellularUniProt_locationNoNoNoNoNo
intracellularintracellularOmniPathNoNoNoNoNo

Protein Complex Composition (1)

1 record.

Component NameComponent Gene SymbolsComponent UniProt IDStoichiometryDatabaseDatabase IDsReferences
ADH1BP003252PDBPDB:1hdzPDB:1hdyPDB:1hszPDB:1dehPDB:1u3vPDB:1htbPDB:1u3uPDB:3hudPDB:1hdx

Isolation & Detection Technology (1)

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationSize Exclusion ChromatographyWestern blottingMORPH132089743
Sequence, Structure & Domains11

Sequences

Length
375
Mass
39,835
Sequence
MSTAGKVIKCKAAVLWEVKKPFSIEDVEVAPPKAYEVRIKMVAVGICHTDDHVVSGNLVTPLPVILGHEAAGIVESVGEGVTTVKPGDKVIPLFTPQCGKCRVCKNPESNYCLKNDLGNPRGTLQDGTRRFTCRGKPIHHFLGTSTFSQYTVVDENAVAKIDAASPLEKVCLIGCGFSTGYGSAVNVAKVTPGSTCAVFGLGGVGLSAVMGCKAAGAARIIAVDINKDKFAKAKELGATECINPQDYKKPIQEVLKEMTDGGVDFSFEVIGRLDTMMASLLCCHEACGTSVIVGVPPASQNLSINPMLLLTGRTWKGAVYGGFKSKEGIPKLVADFMAKKFSLDALITHVLPFEKINEGFDLLHSGKSIRTVLTF
Alternative Products
Event=Alternative splicing; Named isoforms=2; Name=1; IsoId=P00325-1; Sequence=Displayed; Name=2; IsoId=P00325-2; Sequence=VSP_054847
Alternative Sequence
1..40; Missing (in isoform 2)

3D Structural Models

Turn
142..144; 186..188; 259..261; 285..287
Helix
48..54; 102..105; 155..157; 167..170; 171..174; 176..185; 203..214; 227..229; 230..235; 244..246; 251..258; 273..282; 307..310; 320..322; 325..337; 344..346; 353..355; 356..364
Beta Strand
8..15; 23..29; 36..45; 56..58; 62..65; 69..77; 89..92; 99..101; 116..119; 131..133; 136..139; 147..154; 158..160; 195..199; 218..223; 239..242; 262..268; 289..292; 302..304; 314..317; 347..352; 369..374
3D Structure
X-ray crystallography (9)

Domain & Motif Annotations

Protein Families
Zinc-containing alcohol dehydrogenase family
Sequence Similarities
Belongs to the zinc-containing alcohol dehydrogenase family.
Clinical Relevance4
Disease Involvement
FDA approved drug targets
Drug Targets
FDA approved drug targets
Supporting Publications13
PMIDTitleAbstract
40840701Multiomics analysis to evaluate the enrichment of extracellular vesicles from human plasma.No abstract available
41068253Identification of plasma extracellular vesicle protein biomarkers in diabetic retinopathy progression.No abstract available
41307968Extracellular Vesicles Define Discrete Nano-Based Niches Within the Human Haematopoietic System.No abstract available
Page 2 of 2Previous